BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32078126)

  • 1. Genetic removal of the CH1 exon leads to the production of hypofunctional heavy chain-only IgG2a in rats.
    Li Z; Zhang M; Zheng S; Song Y; Cheng X; Yu D; Du L; Ren L; Han H; Zhao Y
    Transgenic Res; 2020 Apr; 29(2):199-213. PubMed ID: 32078126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.
    Zhang T; Cheng X; Yu D; Lin F; Hou N; Cheng X; Hao S; Wei J; Ma L; Fu Y; Ma Y; Ren L; Han H; Yu S; Yang X; Zhao Y
    Front Immunol; 2018; 9():2202. PubMed ID: 30319646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies.
    Nguyen VK; Hamers R; Wyns L; Muyldermans S
    Mol Immunol; 1999 Jun; 36(8):515-24. PubMed ID: 10475606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
    Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
    Front Immunol; 2018; 9():3037. PubMed ID: 30666250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG variable region and VH CDR3 diversity in unimmunized mice analyzed by massively parallel sequencing.
    Lu J; Panavas T; Thys K; Aerssens J; Naso M; Fisher J; Rycyzyn M; Sweet RW
    Mol Immunol; 2014 Feb; 57(2):274-83. PubMed ID: 24211535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct immunoglobulin heavy chain isotypes in a primitive, cartilaginous fish, Raja erinacea.
    Harding FA; Amemiya CT; Litman RT; Cohen N; Litman GW
    Nucleic Acids Res; 1990 Nov; 18(21):6369-76. PubMed ID: 2123029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Transgenic Heavy Chain IgG Mouse Platform as a Source of High Affinity Fully Human Single-Domain Antibodies for Therapeutic Applications.
    Drabek D; Janssens R; van Haperen R; Grosveld F
    Methods Mol Biol; 2022; 2446():121-141. PubMed ID: 35157271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
    Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
    Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a mouse immunoglobulin G that lacks the entire CH1 domain: protein sequencing and small-angle X-ray scattering studies.
    Igarashi T; Sato M; Katsube Y; Takio K; Tanaka T; Nakanishi M; Arata Y
    Biochemistry; 1990 Jun; 29(24):5727-33. PubMed ID: 2116900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring antibodies devoid of light chains.
    Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
    Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes.
    Cory S; Adams JM
    Cell; 1980 Jan; 19(1):37-51. PubMed ID: 6766810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.
    Henry KA; van Faassen H; Harcus D; Marcil A; Hill JJ; Muyldermans S; MacKenzie CR
    Immunogenetics; 2019 Apr; 71(4):307-320. PubMed ID: 30656359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications of immunoglobulin G: a mouse IgG variant that lacks the entire CH1 domain.
    Masuda K; Yamaguchi Y; Kato K; Kim HH; Takahashi N; Shimada I; Arata Y
    Mol Immunol; 1999; 36(15-16):993-1003. PubMed ID: 10698303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The porcine Ig delta gene: unique chimeric splicing of the first constant region domain in its heavy chain transcripts.
    Zhao Y; Pan-Hammarström Q; Kacskovics I; Hammarström L
    J Immunol; 2003 Aug; 171(3):1312-8. PubMed ID: 12874220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of heavy and light chain assembly by modification of heavy chain constant region 1 (CH1): Application for the construction of an anti-paclitaxel fragment antigen-binding (Fab) antibody.
    Yusakul G; Sakamoto S; Tanaka H; Morimoto S
    J Biotechnol; 2018 Dec; 288():41-47. PubMed ID: 30389640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.
    Early P; Huang H; Davis M; Calame K; Hood L
    Cell; 1980 Apr; 19(4):981-92. PubMed ID: 6769593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of ovine Ig gamma 2 constant region heavy chain cDNA and molecular modelling of ruminant IgG isotypes.
    Clarkson CA; Beale D; Coadwell JW; Symons DB
    Mol Immunol; 1993 Sep; 30(13):1195-204. PubMed ID: 8413324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.
    Osborn MJ; Ma B; Avis S; Binnie A; Dilley J; Yang X; Lindquist K; Ménoret S; Iscache AL; Ouisse LH; Rajpal A; Anegon I; Neuberger MS; Buelow R; Brüggemann M
    J Immunol; 2013 Feb; 190(4):1481-90. PubMed ID: 23303672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies.
    Harris KE; Aldred SF; Davison LM; Ogana HAN; Boudreau A; Brüggemann M; Osborn M; Ma B; Buelow B; Clarke SC; Dang KH; Iyer S; Jorgensen B; Pham DT; Pratap PP; Rangaswamy US; Schellenberger U; van Schooten WC; Ugamraj HS; Vafa O; Buelow R; Trinklein ND
    Front Immunol; 2018; 9():889. PubMed ID: 29740455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.